人类微生物组产业发展态势及建议

doi:10.13523/j.cb.20190614

中国生物工程杂志

2019, Vol. 39

Issue (6): 97-103 DOI: 10.13523/j.cb.20190614

研究报告

人类微生物组产业发展态势及建议

施慧琳,王玥,苏燕,徐萍(

)

中国科学院上海生命科学信息中心中国科学院上海营养与健康研究所中国科学院上海生命科学研究院上海 200031

The Development Trend and Suggestions of Human Microbiome Industry

Hui-lin SHI,Yue WANG,Yan SU,Ping XU(

)

Shanghai Information Center for Life Sciences, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China

全文: PDF(9304 KB) HTML

摘要：

近年来,各国政府、高校、企业和公众高度关注人类微生物组与健康研究,旨在全面系统地解析微生物组的结构和功能,以及生理调控机制,为解决健康问题提供新思路,相关研究带动了人类微生物组行业内益生菌、益生元类保健食品和膳食补充剂、粪菌移植产业的发展,也催生了微生物组检测及健康指导、微生态药物产业的崛起。通过梳理全球人类微生物组产业现状,分析相关产业发展面临的主要瓶颈及未来发展方向,并针对中国人类微生物组产业提出了具体的发展建议。

关键词： 人类微生物组; 微生物组检测; 微生态药物

Abstract:

In the recent years, the governments, universities, enterprises and public have paid great attention to human microbiome and health research, which aims at comprehensively and systematically analyzing the structure and function of microbiome, as well as the physiological regulation mechanisms, and providing new ideas for solving health problems. The research drives the development of probiotics and prebiotics health foods and dietary supplements, and fecal microbiota transplantation industry, and also spawns the rise of microbiome testing and health guidance, as well as microecological drug industry. This paper analyzes the status of the global human microbiome industry, and provides the main bottlenecks and future development directions of the industry, and also puts forward the specific development suggestions for the human microbiome industry of China.

Key words: Human microbiome Microbiome testing Microecological drugs

收稿日期: 2018-11-13 出版日期: 2019-07-12

ZTFLH:

Q819

通讯作者: 徐萍 E-mail: xuping@sibs.ac.cn

	服务
	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	施慧琳
	王玥
	苏燕
	徐萍

引用本文:

施慧琳,王玥,苏燕,徐萍. 人类微生物组产业发展态势及建议[J]. 中国生物工程杂志, 2019, 39(6): 97-103.

Hui-lin SHI,Yue WANG,Yan SU,Ping XU. The Development Trend and Suggestions of Human Microbiome Industry. China Biotechnology, 2019, 39(6): 97-103.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20190614 或 https://manu60.magtech.com.cn/biotech/CN/Y2019/V39/I6/97

表1 人类微生物组领域科技创业公司融资不断升级

图1 人类微生物组产业细分领域

表2 国内专注于人类微生物组检测的公司

表3 针对不同适应症研发进程相对较快的微生态药物(数据来源:Cortellis数据库)

图2 美国Seres Therapeutics和Rebiotix公司微生态药物研发管线

[1]	Areas to watch. Science, 2007,318(5858):1848-1849. doi: 10.1126/science.318.5858.1848
[2]	Your microbes, your health . Science, 2013,342(6165):1440-1441.
[3]	2017 sneak peek: What the new year holds for science. [2018-08-09].https://www.nature.com/news/2017-sneak-peek-what-the-new-year-holds-for-science-1. 21231.
[4]	Cleveland clinic innovations top 10 for 2017. [2018-08-09]. https://innovations.clevelandclinic.org/Summit/Top-10-Medical-Innovations/Top-10-for-2017.aspx.
[5]	Human microbiome market by indication (obesity, cancer), application (therapeutic, diagnostic), product (prebiotics, food, drugs), product research (instruments, consumables), technology research (HTS, omics technologies) - Global Forecast to 2025. [2018-08-09]. https://www.researchandmarkets.com/reports/4090365/human-microbiome-market-by-indication-obesity.
[6]	FACT SHEET: announcing the national microbiome initiative. [2018-09-07].https://obamawhitehouse.archives.gov/sites/whitehouse.gov/files/documents/OSTP%20National%20Microbiome%20Initiative%20Fact%20Sheet.pdf.
[7]	张发明, 李潘, 崔伯塔 , 等 . 粪菌移植: 老故事与新未来. 医学争鸣, 2015,6(1):17-22.
	Zhang F M, Li P, Cui B T , et al. Fecal microbiota transplantation: old story, new future. Negative, 2015,6(1):17-22.
[8]	Evelo biosciences and mayo clinic collaborate to advance monoclonal microbials for the treatment of inflammatory and neuroinflammatory diseases. [2018-08-09].https://www.prnewswire.com/news-releases/evelo-biosciences-and-mayo-clinic-collaborate-to-advance-monoclonal-microbials-for-the-treatment-of-inflammatory-and-neuroinflammatory-diseases-300557383.html?tc=eml_cleartime.
[9]	Evelo biosciences announces issuance of U.S.Patent supporting monoclonal microbial oncology trials. [2018-08-09]. https://www.prnewswire.com/news-releases/evelo-biosciences-announces-issuance-of-us-patent-supporting-monoclonal-microbial-oncology-trials-300579737.html.
[10]	Enterome raises 32 million($38.5 million) in a Series D financing.[2018-08-09]. https://www.enterome.com/enterome-raises-e32-million-38-5-million-in-a-series-d-financing/.
[11]	Human microbiome project - core microbiome sampling protocol A. [2018-08-09].https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetPdf.cgi?id=phd002854. 2.
[12]	赵立平, 张晨虹 . 建议启动“国际华族健康微生物组研究计划”. 中国科学院院刊, 2017,32(3):251-259.
	Zhao L P, Zhang C H . Proposal on international healthy Chinese microbiome project. Bulletin of Chinese Academy of Sciences, 2017,32(3):251-259.

[1]	高倩,张宏翔,江洪,叶茂. 全球微生态药物研发现状及发展趋势 ^*[J]. 中国生物工程杂志, 2020, 40(1-2): 166-173.

Viewed

Full text

Abstract

Cited

Shared

Discussed